Co-loading of doxorubicin and anti-cancer peptide LL-37 on covalently functionalized carbon nanotubes; a molecular dynamics simulation study

•Development of advanced molecular modeling for drug delivery systems.•Investigations on functionalization of CNT (carbon nanotube) as drug carrier.•Co-loading of doxorubicin (DOX) and LL-37 on covalently functionalized CNTs.•Hydroxyl-functionalized CNT is a suitable carrier in the ratio of 1:1 (DOX...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of molecular liquids 2023-09, Vol.386, p.122444, Article 122444
Hauptverfasser: Wu, Xiaoyu, Huan, Xiangkun, Zhu, Yimiao, Yang, Gang, Yang, Hao, Wu, Zhenfeng, Xu, WenWen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Development of advanced molecular modeling for drug delivery systems.•Investigations on functionalization of CNT (carbon nanotube) as drug carrier.•Co-loading of doxorubicin (DOX) and LL-37 on covalently functionalized CNTs.•Hydroxyl-functionalized CNT is a suitable carrier in the ratio of 1:1 (DOX: LL-37) An investigation of covalently functionalized carbon nanotubes (f-CNTs) loaded with doxorubicin (DOX) and LL-37 was performed using molecular dynamics simulations. With carboxyl, hydroxyl, and amine groups covalently attached, f-CNTs were functionalized. Adsorption of DOX molecules and LL-37 was investigated in two molar proportions. Binding energy, radial distribution function, and conformational changes of the peptide were investigated. In order to choose a suitable carrier, the structural properties of LL-37 adsorbed on f-CNTs were compared with the aqueous medium. The obtained results demonstrated that hydroxyl-functionalized CNT is a suitable carrier in the ratio of 1:1 (DOX: LL-37), and also amine-functionalized CNT is a suitable carrier in the ratio of 2:1 (DOX: LL-37), which has kept the structure of the peptide stable. Dual drug delivery systems can benefit from these results.
ISSN:0167-7322
DOI:10.1016/j.molliq.2023.122444